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Summary. Ozone application in a complex treatment of patients with diabetes complicated by pyoinflammatory processes 
has an apparent therapeutic effect and prevents the development of the  relapse and complications of the disease promoting 
significant improvements of direct and remote results of treatment of the given pathology.
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Резюме. Применение озона при комплексном лечении пациентов с сахарным диабетом, осложненным гнойно-
воспалительными процессами, имеет очевидный терапевтический эффект и предотвращает развитие рецидива 
и осложнений заболевания, способствуя значительному улучшению прямых и отдаленных результатов лечения 
данной патологии.
Ключевые слова:  сахарный диабет, гнойно-воспалительные процессы, переокисное окисление липидов, 
озонотерапия.
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Introduction. Diabetes mellitus  remains one of the pressing 
problems of medicine, since it is one of the most common endocrine 
diseases with a steady upward trend. Along with oncological and 
cardiovascular diseases, diabetes mellitus is one of the most common 
causes of disability and mortality in patients [4, 6, 8]. Over the past ten 
years, the prevalence of diabetes in Ukraine has increased by 1.5 times 
and is estimated to be up to one million patients Scientific data analysis 
shows a steady increase in the number of patients with diabetes, and 
in developed countries reaches more than 6% of the population [2, 5].
Despite some advances in the treatment of diabetic patients 
with severe localized wound infection, surgical treatment results can 
not be considered satisfactory [2, 7]. The accumulated experience in 
the medical practice of the use of physical factors with a therapeutic 
purpose of influence on the stimulation of reparative processes 
associated with targeted pharmacotherapy, confirm the correctness 
of the search attempts. Ozonotherapy have been widely used for this 
purpose in recent years [1, 8].
It is known that the condition of the blood coagulation system plays 
an essential role in the healing of wounds in the surgical treatment [1, 
5, 6, 7]. Special studies devoted to the influence of ozone on the blood 
coagulation system, as a factor affecting the wound healing in diabetes 
mellitus with purulent-inflammatory complications have not been found 
in the available scientific literature. Hence, it is important to study the 
ozone influence on blood clotting in diabetes with pyoinflammatory 
processes [2, 3, 4, 6].
From the surgical point of view,  topicality  of this problem is first 
of all stipulated by the fact that purulent-necrotic processes develop in 
more than 30-70% diabetic patients and 50% of hospitalized patients 
need surgical care concerning these complications [1, 3, 4].
With regard of to the mentioned facts, it becomes evident that 
the effective methods of complex treatment of purulent processes in 
diabetic patients should be searched in order to introduce into clinical 
practice the effective methods of conservative treatment and new ways 
of reparative processes activation. For this purpose ozonotherapy has 
recently become widely used.
Material and methods. 124 diabetic patients with pyoinflammatory 
complications have been examined. The main group - 53 (42.7%) 
patients, along with comprehensive treatment underwent intravenous 
ozone therapy. The control group -71 (57.2%) patients were treated by 
conventional methods.
Intravenous administration of ozonized physiological solution 
was performed in all patients of the main group, along with traditional 
therapy, similar in composition to the control group of patients [6]. 
Coagulogram indices, lipid peroxidation,  parameters were determined.
Discussion of results.
According to some authors, in diabetic patients with pyoinflammatory 
lesion of soft tissues the level of lipid peroxidation end product – 
malonic aldehyde in the wound increases. Inhibition of AOP manifests 
by a significant decrease in tissue retinol and tocopherol in particular, as 
well as decreased activity of glutathione reductase. The most effective 
treatment methods in terms of lipid peroxidation stabilization are those 
including ultraviolet blood irradiation, low-intensity laser irradiation and 
sorbents application [7, 9].
Hypercoagulation syndrome  vith microthromboses development 
and whieh is manifested by is pathognomonic an increased thrombocytes 
aggregation activity. Combined with decreased anticoagulant and 
fibrinolytic blood activity it stipulates  the widespread use of reocorrectors 
together with anticoagulants and antiaggregants [8].
The results of the coagulogram study in diabetic patients with 
pyoinflammatory complications (Table 1) showed that in the control 
group of patients on admission, during the treatment and at discharge 
significant changes were not detected concerning to the prothrombin 
index, recalcification time, thrombin time, hematocrit, and fibrinogen. In 
the context of ozone therapy application in the main group of patients 
on admission, during the treatment and at discharge the  significant 
coagulogram parameters  changes were not revealed.
These changes against a background of typical positive clinical 
effects of ozone therapy can be regarded as a favourable signs of 
coagulogram parameters for the application of this method of treatment 
in diabetic patients with pyoinflammatory complications.
The analysis of lipid peroxidation indices, AOP, OPM parameters 
in diabetic patients with pyoinflammatory complications (Table 2) 
showed that in the control group of patients on admission, during the 
treatment and at discharge significant changes were not detected as to 
the activity of AOP factor – ceruloplasmin, lipid peroxidation product – 
malonic aldehyde and OPM. In the context of ozone therapy application 
in the main group of patients on admission, during the treatment and at 
discharge the parameters were not considerably changed either.
Indices
Main group Control group
On admission During treatment At discharge On admission During treatment At discharge
Prothrombin index (%) 89,96±1,3 94,50±1,6 90,73±1,2 94,39±1,2 81,96±1,9 87,36±1,8
Recalcification time (s) 105 ±0,9 100±0,7 98±1,1 110±0,8 105±1,1 99±0,7
Thrombin time (s) 19,30±0,4 19,43±0,6 19,50±0,4 19,35±0,6 19,40±0,3 19,43±0,3
Hematocrit  (%) 36,84±0,2 32,29±0,1 32,75±0,3 40,47±1,1 38,15±0,2 37,81±0,3
Fibrinogen (g/l) 6,77±0,2 5,90±0,1 5,70±0,1 6,41±0,1 4,87±0,2 4,12±0,1
Р >0,05 ≤0,001 ≤0,001 >0,05 ≤0,001 ≤0,001
Indices
Main group Control group
On admission During treatment At discharge On admission During treatment At discharge
Ceruloplasmin (Е/g of plasm) 5,2±0,10 5,1±0,30 5,1±0,10 5,3±0,30 5,5±0,7 5,5±0,50
Malonic aldehyde (micromole/l of serum) 0,23±0,10 0,24±0,05 0,20±0,10 0,22±0,10 0,23±0,10 0,19±0,10
Degree of oxidative modification 
of proteins (∆Е/ml of plasm) 2,2±0,05 2,2±0,04 2,0±0,06 1,5±0,05 1,4±0,03 1,6±0,04
Table 1. Coagulogram characteristics in diabetic mellitus patients with pyoinflammatory complications  using ozonotherapy 
Table 2. Characteristics of lipid peroxidation, AOP, OPM parameters in diabetic patients with pyoinflammatory complications 
Note: Р – index of statistical significance
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In our opinion the coagulogram parameters, lipid peroxidation, AOP, 
OPM indices against the background of typical positive clinical effects 
of ozone therapy application can be regarded as favorable biochemical 
signs for the use of the given method of treatment in diabetic patients 
with pyoinflammatory complications.
Determination of blood glucose levels at 3, 6, 14 days after surgery 
in both groups showed that in patients in the primary and control groups, 
the level of glycemia at the beginning of treatment was approximately 
at the same level.    However, at a later date, starting from the 7th 
day of treatment, the patients in the main group after intravenous 
administration of the ozonized saline solution determined the probable 
difference between these parameters compared with the control group. 
Subsequently, blood glucose levels in both groups were aligned with 
a tendency for greater reduction and stabilization in the main group.
As a result of disturbances of metabolic processes occurring 
in patients with diabetes with purulent-inflammatory processes of 
soft tissues, favorable conditions for the development of pathogenic 
microorganisms in the zone of inflammatory process are created. 
Distorted by the long-term hyperglycemic state, metabolism leads to 
significant disorders of metabolic processes in biological tissues of the 
human body. 
Microcirculatory disorders that arise along with this, combined 
with defects of the nervous trophy, significantly impair the protective 
properties in the zone of already localized, under such conditions, 
inflammatory process. 
The increased propensity to thrombosis in small vessels potentiates 
manifestations of local tissue ischemia and, as a result, leads to further 
progression and proliferation of purulent-inflammatory process. Usually, 
the course of the disease is approaching fatal changes in the tissues of 
the body, the most vulnerable are the lower limbs. 
Such features of the manifestations of the disease indicate the 
need for further search for medical, operational and technical and other 
types of therapeutic innovations of general and local orientation, aimed 
at suppressing the development of the microflora in the nucleus of 
purulent inflammatory focus.
Taking into account the above mentioned, the optimally chosen 
method of complex health improvement on the affected area of 
the patient, implemented taking into account the quantitative and 
specific characteristics of the microbial spectrum in the cell purulent-
inflammatory process, provides the expected success of the treatment.
Conclusions. 
1. Implementation of the positive effects of ozone therapy in the 
clinic in diabetic patients with pyoinflammatory complications is not 
accompanied by the development of damage reactions on the level of 
hemostasis parameters and blood biochemical parameters.
2. The above mentioned fact confirms the expediency of intravenous 
ozone therapy application clinically in this category of patients.
